U.S. President Trump issued an Executive Order on 3 March 2025 that increases the ad valorem tariffs on products from China. The executive order amends previous actions addressing the synthetic opioid supply chain from China. It raises the tariff rate on Chinese products from 10% to 20% due to China's insufficient efforts to combat the influx of synthetic opioids like fentanyl into the U.S.